Business Context and Reporting Period
This Form 8-K was filed by Milestone Pharmaceuticals Inc. on September 18, 2019. The company is incorporated in Québec and its common shares trade on The Nasdaq Stock Market LLC under the symbol "MIST". The report addresses a corporate governance event rather than financial performance.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to the disclosure of a director's departure and contains no financial statements or operational metrics.
Material Changes
The material change reported is the resignation of Nilesh Kumar from the Board of Directors, effective September 18, 2019. The company explicitly states that the resignation is not due to any disagreement with the Company regarding operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on future performance, or discussion of risks and contingencies beyond the standard disclosure regarding the director's departure.
Key Facts for Investor Verification
- Nilesh Kumar resigned from the Board of Directors and all associated committees effective September 18, 2019.
- The resignation was voluntary and not related to any disagreement with the company.
- The report was signed by Amit Hasija, Chief Financial Officer, on September 20, 2019.
- No financial data or operational updates are included in this specific filing.